-
NMPA and NHC Jointly Issued the Announcement on Regulations for the Administration of Drug Clinical Trial Institutions
2019-11-29
NMPA has formulated,in conjunction with the National Health and Health Commission (NHC), the Regulations for the Administration of Drug Clinical Trial Institutions, which has been released on November 29, 2019, and shall take effect as from December 1, 2019.
-
NMPA Issued the Announcement on Issues Pertaining to the Implementation of the Drug Administration Law of the People's Republic of China
2019-11-29
NMPA issued the Announcement on Issues Pertaining to the Implementation of the Drug Administration Law of the People's Republic of China (2019 No. 103).
-
NMPA Issued the Technical Guidelines for Aluminum-Adjuvant-containing Preventive Vaccines
2019-12-10
NMPA has organized the formulation of the Technical Guidelines for Aluminum-Adjuvant-containing Preventive Vaccines, which has been released on December 10, 2019.
-
NMPA Issued the Announcement on Enabling the New Version of Management System for Import Filing of Drugs and Medicinal Materials
2019-12-19
NMPA and the General Administration of Customs have collaboratively established a management system for import filing of pharmaceuticals and medicinal material imports.
-
NMPA Issued the Guidelines for Clinical Trials of Drugs for Treatment of Nonalcoholic Steatohepatitis (Interim)
2019-12-20
NMPA has organized the formulation of the Guidelines for Clinical Trials of Drugs for Treatment of Nonalcoholic Steatohepatitis (Interim), which was released on December 20, 2019.
